China Universal Asset Management Company’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$186K Buy
5,635
+484
+9% +$20.5K 0.01% 358
2025
Q4
$238K Sell
5,151
-371
-7% -$15.5K 0.02% 333
2025
Q3
$193K Sell
5,522
-934
-14% -$32.5K 0.02% 339
2025
Q2
$191K Buy
6,456
+141
+2% +$4.02K 0.02% 315
2025
Q1
$189K Sell
6,315
-523
-8% -$16K 0.02% 318
2024
Q4
$196K Buy
6,838
+642
+10% +$21.2K 0.02% 324
2024
Q3
$239K Buy
6,196
+2,352
+61% +$83.9K 0.03% 284
2024
Q2
$124K Sell
3,844
-2,276
-37% -$78.9K 0.02% 288
2024
Q1
$238K Buy
6,120
+2,344
+62% +$82K 0.03% 272
2023
Q4
$116K Buy
3,776
+2,877
+320% +$72.1K 0.02% 265
2023
Q3
$20.1K Buy
899
+445
+98% +$10.1K 0.01% 297
2023
Q2
$9.76K Sell
454
-8
-2% -$182 ﹤0.01% 320
2023
Q1
$11.1K Buy
462
+121
+35% +$3.21K ﹤0.01% 286
2022
Q4
$7.91K Buy
341
+21
+7% +$423 ﹤0.01% 248
2022
Q3
$5K Buy
+320
New +$5.64K ﹤0.01% 269

Other funds holding COLL